Eyal C. Attar - 11 Oct 2022 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Medical Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
11 Oct 2022
Net transactions value
$0
Form type
4
Filing time
12 Oct 2022, 16:24:41 UTC
Previous filing
07 Jun 2022
Next filing
08 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Employee Stock Option (right to buy) Award $0 +364,000 $0.000000 364,000 11 Oct 2022 Common Stock 364,000 $3.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares underlying the option vest on October 11, 2023, with the remainder vesting in equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.